<DOC>
	<DOCNO>NCT01067118</DOCNO>
	<brief_summary>The purpose study determine use Linjeta ( tm ) insulin compare Humalog result significantly low episode hyperglycemia hypoglycemia breakfast meal .</brief_summary>
	<brief_title>A Randomized Control Trial Comparing Linjeta Versus Humalog Pumps : Effect Postprandial Blood Sugars .</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin , Short-Acting</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<criteria>1 ) Type 1 diabetes least 1 year 1 . The diagnosis type 1 diabetes base investigator¡s judgment ; C peptide level antibody determination need . 2 ) Age : 18 year old ¨C 49.99 year old 3 ) Continuous subcutaneous insulin infusion ( CSII ) therapy least 3 month 4 ) Participant consent demonstrate signing IRB approve document 6 ) HgA1c ¡Ü 9 % 7 ) If participant female reproductive potential , willing avoid pregnancy pregnancy test negative . 1 ) Chronic oral steroid use 2 ) The presence significant medical disorder judgment investigator affect wear sensor completion aspect protocol . 3 ) Known clinical history celiac disease inflammatory bowel disease . 4 ) Participants negative antiendomysial antibody antitissue transglutaminase antibody within one year enrollment . 5 ) Cystic Fibrosis 6 ) Inpatient psychiatric treatment past 6 month . 7 ) Currently pregnant lactating , anticipate get pregnant next one year . 8 ) Clinical diagnosis gastroparesis . 9 ) Insulin bind capacity great 10 microunits per litter</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>